참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Methanesulfonyl chloride | HCID 31297 | — |
| 반응물 | alpha-Methyl-4-pyridinemethanol | HCID 90919 | — |
| 반응물 | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| 반응물 | tert-Butyl 4-(1-(pyridin-2-yl)ethyl)piperazine-1-carboxylate | HCID 60137623 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 용매 | Ethylacetate methanol | HCID 21584119 | — |
| 생성물 | tert-Butyl 4-(1-(pyridin-4-yl)ethyl)piperazine-1-carboxylate | HCID 46868084 | — |
반응 단계
This was prepared using the same procedure as for tert-butyl 4-(1-(pyridin-2-yl)ethyl)piperazine-1-carboxylate, but here using 1-(pyridin-4-yl)ethanol (J. Chem. Soc., Perkin Trans. 1, 2000, 4439-4444) (100 mg, 0.81 mmol), triethylamine (5.0 eq, 4.05 mmol, 0.56 mL), MsCl (2.0 eq, 1.62 mmol, 0.13 mL), CH2Cl2 (4 mL) at 0° C. for 30 minutes, then N—BOC piperazine (4.0 eq, 3.24 mmol, 605 mg), DMSO (3 mL) at 60° C. for 18 h. Work up as described for tert-butyl 4-(1-(pyridin-2-yl)ethyl)piperazine-1-carboxylate, followed by column chromatography (EtOAc-MeOH, 95:5) gave the product (163 mg, 69% for two steps) as a colourless oil; 1H-NMR (500 MHz, CDCl3) 1.50 (s, 9H, C(CH3)3), 1.72 (s, br, 3H, CH3), 2.42-2.60 (m, 4H, piperazine N(CH2)2), 3.49 (s, br, 5H, CH & piperazine N(CH2)2), 7.32 (d, J=5.7 Hz, 2H, pyridine H-3 & H-5), 8.59 (d, J=5.7 Hz, 2H, pyridine H-2 & H-6);
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08088761B2 |
|---|
| 출처 데이터셋 | uspto-grants-2012_01 |
|---|
| ORD ID | ord-b9b7d9100cc74dae9ea321106d3a7f6a |
|---|
| 출처 메모 | uspto-grants-2012_01 |
|---|